Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZR Kezar Life Sciences Inc.

盘前交易 09-18 04:05:23 EDT

0.5750

+0.0020

+0.35%

最高0.5893	最低0.5600	成交量48.14万
今开0.5715	昨收0.5730	日振幅5.11%
总市值4,195万	流通市值3,027万	总股本7,296万
成交额27.56万	换手率0.91%	流通股本5,264万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZR","market":"US","secType":"STK","nameCN":"Kezar Life Sciences Inc.","latestPrice":0.575,"timestamp":1726603200000,"preClose":0.573,"halted":0,"volume":481446,"delay":0,"floatShares":52640578,"shares":72962220,"eps":-1.354562,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.002,"latestTime":"09-18 04:05:23 EDT","open":0.5715,"high":0.5893,"low":0.56,"amount":275622.92425080005,"amplitude":0.051134,"askPrice":0.92,"askSize":200,"bidPrice":0.2462,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.354562,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726666200000},"adr":0,"listingDate":1529553600000,"adjPreClose":0.575,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.58,"preClose":0.575,"latestTime":"18:48 EDT","volume":4614,"amount":2639.31,"timestamp":1726613298342},"volumeRatio":1.7951903629880428,"impliedVol":1.3302,"impliedVolPercentile":0.7729},"requestUrl":"/m/hq/s/KZR","defaultTab":"news","newsList":[{"id":"2460241716","title":"Kezar Life Sciences, Inc.2024财年第二财季实现净利润-21.55百万美元，同比增加11.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241716","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241716?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824040,"startTime":"0","endTime":"0","summary":"8月17日，Kezar Life Sciences, Inc.公布财报，公告显示公司2024财年第二财季净利润为-21.55百万美元，同比增加11.35%；其中营业收入为0.00美元，每股基本收益为-0.30美元。机构评级：截至2024年8月17日，当前有3家机构对Kezar Life Sciences, Inc.目标价做出预测，其中目标均价为7.33美元，其中最低目标价为2.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006369f31b1c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170006369f31b1c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR"],"gpt_icon":0},{"id":"2459172605","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大涨5.12%报0.610美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459172605","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459172605?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:34","pubTimestamp":1723642482,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时34分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.12%。截至发稿，该股报0.610美元/股，成交量1998股，换手率0.00%，振幅0.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cormedix Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为52.97%、52.86%、43.81%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Genprex, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为44.00%、33.56%、17.45%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213443ab5daf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814213443ab5daf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2458898532","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458898532","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458898532?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:32","pubTimestamp":1723469547,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时32分，Kezar Life Sciences, Inc.股票出现异动，股价快速拉升6.33%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为39.84%、19.87%、8.54%，振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、Abcellera Biologics Inc.，振幅分别为23.21%、22.55%、12.69%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132279f249035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132279f249035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2457902897","title":"Kezar Life Sciences, Inc.盘中异动 快速拉升5.98%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457902897","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457902897?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:33","pubTimestamp":1722951192,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时33分，Kezar Life Sciences, Inc.股票出现异动，股价急速上涨5.98%。截至发稿，该股报0.620美元/股，成交量7360股，换手率0.01%，振幅0.00%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为782.17%、308.85%、205.07%，振幅较大的相关个股有Vbi Vaccines, Inc.、Actinium Pharmaceuticals, Inc. 、Tenax Therapeutics, Inc.，振幅分别为76.79%、22.98%、17.81%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062133139f14369f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062133139f14369f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2457044281","title":"Kezar Life Sciences Inc    预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457044281","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457044281?lang=zh_cn&edition=full","pubTime":"2024-08-06 20:53","pubTimestamp":1722948790,"startTime":"0","endTime":"0","summary":"   * Kezar Life Sciences Inc    将于8月8日公布截至2024年6月30日的业绩(估计)，预计季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司预计将实现75万美元的营收。* LSEG 分析师对 Kezar 生命科学公司的平均预期是每股亏损 32 美分。* 华尔街对 Kezar Life Sciences Inc 的 12 个月目标价中位数为 7.00 美元，高于上一交易日 0.59 美元的收盘价。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kezar Life Sciences Inc    预计每股亏损 32 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2457781457","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457781457","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457781457?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864745,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Kezar Life Sciences, Inc.股票出现波动，股价大幅下挫5.40%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为979.82%、34.00%、13.54%，振幅较大的相关个股有Cue Biopharma, Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为12.33%、12.19%、11.60%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052132259f106f10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052132259f106f10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2453888168","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.13%报0.665美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453888168","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453888168?lang=zh_cn&edition=full","pubTime":"2024-07-24 22:54","pubTimestamp":1721832862,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日22时54分，Kezar Life Sciences, Inc.股票出现波动，股价大幅上涨5.13%。截至发稿，该股报0.665美元/股，成交量5.8057万股，换手率0.08%，振幅4.90%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7480.25%、1180.01%、618.30%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.79%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724225422941fa2e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724225422941fa2e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRMA","KZR","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2452193508","title":"Kezar Life Sciences, Inc.盘中异动 下午盘股价大涨5.32%报0.685美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452193508","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452193508?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:52","pubTimestamp":1721238769,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日01时52分，Kezar Life Sciences, Inc.股票出现异动，股价大幅拉升5.32%。截至发稿，该股报0.685美元/股，成交量33.2488万股，换手率0.46%，振幅5.75%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Aditxt, Inc.涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3751.61%、1416.25%、301.75%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Cyclerion Therapeutics, Inc.、Aditxt, Inc.，振幅分别为76.39%、48.13%、46.25%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718015249941f7f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718015249941f7f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2452691242","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452691242","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452691242?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:09","pubTimestamp":1721146162,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日00时09分，Kezar Life Sciences, Inc.股票出现波动，股价大幅上涨5.21%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3225.14%、1269.95%、380.53%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nutriband Inc C/Wts 、Virpax Pharmaceuticals, Inc.，振幅分别为79.41%、70.56%、61.68%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717000923af929c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717000923af929c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2450536837","title":"Kezar Life Sciences, Inc.盘中异动 大幅拉升7.75%报0.674美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450536837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450536837?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791065,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，Kezar Life Sciences, Inc.股票出现波动，股价快速拉升7.75%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为641.19%、73.08%、22.34%，振幅较大的相关个股有Zura Bio Limited C/Wts 、Qualigen Therapeutics, Inc.、Forte Biosciences, Inc.，振幅分别为20.00%、9.21%、9.00%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213105aef97a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712213105aef97a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2450698365","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大涨5.06%报0.596美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450698365","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450698365?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:50","pubTimestamp":1720705833,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时50分，Kezar Life Sciences, Inc.股票出现波动，股价急速拉升5.06%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Terns Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为466.91%、307.85%、272.60%，振幅较大的相关个股有Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为82.31%、73.13%、39.71%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711215034941f646b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711215034941f646b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2450508120","title":"Kezar Life Sciences, Inc.盘中异动 下午盘急速下挫5.20%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450508120","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450508120?lang=zh_cn&edition=full","pubTime":"2024-07-09 03:04","pubTimestamp":1720465499,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日03时04分，Kezar Life Sciences, Inc.股票出现波动，股价快速下跌5.20%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Annovis Bio, Inc.较为活跃，换手率分别为5558.45%、212.56%、188.54%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Annovis Bio, Inc.，振幅分别为121.11%、83.58%、56.04%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090304599681ab57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090304599681ab57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","KZR","BK4007"],"gpt_icon":0},{"id":"2448524251","title":"Kezar Life Sciences, Inc.盘中异动 快速跳水5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448524251","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448524251?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:49","pubTimestamp":1719928184,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时49分，Kezar Life Sciences, Inc.股票出现异动，股价快速跳水5.55%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Moolec Science Sa C/Wts 、Revelation Biosciences Inc C/Wts 10/01/2027 、Zura Bio Limited C/Wts 涨幅较大，Gri Bio, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为40.15%、20.90%、10.43%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Ocean Biomedical Inc C/Wts 14/02/2028 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为39.00%、27.93%、25.84%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702214945941f322a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702214945941f322a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2442714557","title":"Kezar Life Sciences, Inc.盘中异动 股价大涨5.15%报0.745美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442714557","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442714557?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:05","pubTimestamp":1718201144,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时05分，Kezar Life Sciences, Inc.股票出现异动，股价急速拉升5.15%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为65.93%、28.22%、8.20%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences Inc C/Wts 10/01/2027 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为58.42%、52.63%、51.41%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612220544941ee15e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612220544941ee15e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2442822225","title":"Kezar Life Sciences, Inc.盘中异动 下午盘快速拉升5.16%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442822225","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442822225?lang=zh_cn&edition=full","pubTime":"2024-06-11 01:59","pubTimestamp":1718042356,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日01时59分，Kezar Life Sciences, Inc.股票出现异动，股价快速上涨5.16%。截至发稿，该股报0.720美元/股，成交量33.8138万股，换手率0.46%，振幅5.70%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611015916941ed735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611015916941ed735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2441470307","title":"Kezar Life Sciences, Inc.盘中异动 下午盘大幅跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441470307","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441470307?lang=zh_cn&edition=full","pubTime":"2024-06-07 01:05","pubTimestamp":1717693524,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日01时05分，Kezar Life Sciences, Inc.股票出现异动，股价急速下挫5.42%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Virax Biolabs Group Limited、Fibrobiologics, Inc.、Replimune Group, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3040.45%、83.16%、39.04%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、86.92%、70.00%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607010524aef3d5ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607010524aef3d5ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2435305341","title":"Kezar Life Sciences, Inc.盘中异动 急速下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435305341","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435305341?lang=zh_cn&edition=full","pubTime":"2024-05-14 01:17","pubTimestamp":1715620641,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日01时17分，Kezar Life Sciences, Inc.股票出现波动，股价快速下跌5.36%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 、诺瓦瓦克斯医药涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为90.68%、72.99%、65.53%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、诺瓦瓦克斯医药、Tevogen Bio Holdings Inc.，振幅分别为85.56%、50.11%、45.71%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051401172179276483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051401172179276483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2434785219","title":"Kezar Life Sciences, Inc.盘中异动 早盘股价大跌5.07%报0.776美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434785219","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434785219?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:13","pubTimestamp":1715350386,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时13分，Kezar Life Sciences, Inc.股票出现异动，股价大幅下挫5.07%。截至发稿，该股报0.776美元/股，成交量21.2632万股，换手率0.29%，振幅4.31%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022130687e87205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022130687e87205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2433274012","title":"Kezar Life Sciences Inc    预计每股亏损 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433274012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433274012?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:23","pubTimestamp":1715081021,"startTime":"0","endTime":"0","summary":"   * Kezar Life Sciences Inc    预计将在5月9日公布截至2024年3月31日的季度业绩(预计)，季度收入将有所增长。* 根据 LSEG 的数据，5 位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司预计将实现 40 万美元的营收。* LSEG 分析师对 Kezar 生命科学公司的平均预期是每股亏损 33 美分。* 华尔街对 Kezar Life Sciences Inc 的 12 个月目标价中位数为 13.00 美元，高于上一交易日 0.81 美元的收盘价。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZR"],"gpt_icon":0},{"id":"2433440476","title":"Kezar Life Sciences, Inc.盘中异动 大幅跳水6.34%报0.803美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433440476","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433440476?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:36","pubTimestamp":1715013365,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时36分，Kezar Life Sciences, Inc.股票出现波动，股价急速下跌6.34%。截至发稿，该股报0.803美元/股，成交量32.4468万股，换手率0.45%，振幅4.89%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700360687e85df0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050700360687e85df0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kezarlifesciences.com","stockEarnings":[{"period":"1week","weight":0.0268},{"period":"1month","weight":-0.0626},{"period":"3month","weight":-0.122},{"period":"6month","weight":-0.4041},{"period":"1year","weight":-0.5287},{"period":"ytd","weight":-0.3931}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kezar Life Sciences, Inc.于2015年2月19日根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，发现并开发新型小分子疗法，用于治疗免疫介导疾病和癌症中未满足的需求。该公司正在推进两个药物开发计划，利用细胞功能的不同调节剂：第一个针对负责免疫系统细胞中蛋白质降解并驱动免疫细胞功能的许多关键方面的免疫蛋白酶体，第二个针对位于内质网上并代表蛋白质分泌途径开始的Sec61转座子。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.101182},{"month":2,"riseRate":0.833333,"avgChangeRate":0.110013},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.094959},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.079081},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.18188},{"month":6,"riseRate":0.333333,"avgChangeRate":0.038813},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.058216},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.003228},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.009505},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.065252},{"month":11,"riseRate":0.833333,"avgChangeRate":0.203618},{"month":12,"riseRate":0.5,"avgChangeRate":0.060618}],"exchange":"NASDAQ","name":"Kezar Life Sciences Inc.","nameEN":"Kezar Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kezar Life Sciences Inc.,KZR,Kezar Life Sciences Inc.股票,Kezar Life Sciences Inc.股票老虎,Kezar Life Sciences Inc.股票老虎国际,Kezar Life Sciences Inc.行情,Kezar Life Sciences Inc.股票行情,Kezar Life Sciences Inc.股价,Kezar Life Sciences Inc.股市,Kezar Life Sciences Inc.股票价格,Kezar Life Sciences Inc.股票交易,Kezar Life Sciences Inc.股票购买,Kezar Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kezar Life Sciences Inc.(KZR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kezar Life Sciences Inc.(KZR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}